Physician profile
Susan E Funk
NPI 1841273331
$2,043.12
in general payments reported to CMS, 2019-2025
17 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.47 · 2020: $123 · 2021: $86.45 · 2022: $567 · 2023: $505 · 2024: $311 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $999.01 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $263.11 | 2022-2024 | Airsupra, Farxiga |
| Amgen INC. | $200.24 | 2022-2025 | Repatha, Otezla, Otezla |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.41 | 2022-2024 | Xifaxan |
| Amarin Pharma, INC. | $82.15 | 2019-2021 | |
| Abbvie INC. | $76.09 | 2021-2022 | |
| Mannkind Corporation | $30.24 | 2022-2023 | Afrezza |
| Biohaven Pharmaceutical Holding Company LTD. | $27.17 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.66 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.47 | 2025 | Nuzyra |
| Phadia US INC. | $17.63 | 2025 | Immunocap |
| Astellas Pharma US INC | $17.13 | 2020 | |
| Glaxosmithkline, LLC. | $15.28 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Funk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.